(Q68194610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1624025%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1624025%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

Y. Watanabe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1624025

17 October 2022

G. Nakamura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1624025

17 October 2022

H. Matsuguchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1624025

17 October 2022

M. Nozaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1624025

17 October 2022

M. Sano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1624025

17 October 2022

H. Nakano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1624025

17 October 2022

language of work or name

English

0 references

publication date

1 July 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1624025%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 September 2019

https://api.elsevier.com/content/article/PII:S0015028216551383?httpAccept=text/xml

1 reference

10.1016/S0015-0282(16)55138-3

DOI

https://api.crossref.org/works/10.1016/S0015-0282(16)55138-3

https://api.elsevier.com/content/article/PII:S0015028216551383?httpAccept=text/plain

17 October 2022

1 reference

10.1016/S0015-0282(16)55138-3

DOI

https://api.crossref.org/works/10.1016/S0015-0282(16)55138-3

17 October 2022

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1624025%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1624025%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1624025%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

66-71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1624025%20AND%20SRC:MED&resulttype=core&format=json

A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955138-3

Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955138-3

Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955138-3

Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955138-3

Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955138-3

Goserelin therapy before surgery for uterine fibroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955138-3

Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955138-3

Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955138-3

Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955138-3

A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955138-3

A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955138-3

10.1016/S0015-0282(16)55138-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1624025%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference